Central Trust Company’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-73
Closed -$9K 1194
2021
Q1
$9K Hold
73
﹤0.01% 929
2020
Q4
$11K Buy
+73
New +$11K ﹤0.01% 884